Target Price | €27.86 |
Price | €22.58 |
Potential |
23.38%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target SCHOTT Pharma 2026 .
The average SCHOTT Pharma target price is €27.86.
This is
23.38%
register free of charge
€37.00
63.86%
register free of charge
€20.00
11.43%
register free of charge
|
|
A rating was issued by 12 analysts: 6 Analysts recommend SCHOTT Pharma to buy, 4 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the SCHOTT Pharma stock has an average upside potential 2026 of
23.38%
register free of charge
|
Sep '24 |
2025 Estimates |
|
---|---|---|
Revenue Million € | 957.09 | 1,018.34 |
6.46% | 6.40% | |
EBITDA Margin | 24.66% | 26.74% |
4.95% | 8.45% | |
Net Margin | 15.58% | 14.83% |
7.93% | 4.81% |
11 Analysts have issued a sales forecast SCHOTT Pharma 2025 . The average SCHOTT Pharma sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an SCHOTT Pharma EBITDA forecast 2025. The average SCHOTT Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 SCHOTT Pharma Analysts have issued a net profit forecast 2025. The average SCHOTT Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Sep '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 0.99 | 1.00 |
1.98% | 1.01% | |
P/E | 22.51 | |
EV/Sales | 3.33 |
8 Analysts have issued a SCHOTT Pharma forecast for earnings per share. The average SCHOTT Pharma EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
EQUI.TS |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
DZ BANK |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
BERENBERG |
Locked
➜
Locked
|
Locked | Dec 15 2024 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
BNP PARIBAS EXANE |
Locked
➜
Locked
|
Locked | Dec 08 2024 |
Analyst Rating | Date |
---|---|
Locked
EQUI.TS:
Locked
➜
Locked
|
Dec 19 2024 |
Locked
DZ BANK:
Locked
➜
Locked
|
Dec 18 2024 |
Locked
BERENBERG:
Locked
➜
Locked
|
Dec 15 2024 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Dec 11 2024 |
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Dec 11 2024 |
Locked
BNP PARIBAS EXANE:
Locked
➜
Locked
|
Dec 08 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.